K Pharma (TSE:4896) Additional Paid-In Capital : 円3,003 Mil(As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Additional Paid-In Capital?

K Pharma's quarterly additional paid-in capital increased from Sep. 2023 (円2,249 Mil) to Dec. 2023 (円3,003 Mil) but then stayed the same from Dec. 2023 (円3,003 Mil) to Mar. 2024 (円3,003 Mil).

K Pharma's annual additional paid-in capital increased from Dec. 2021 (円699 Mil) to Dec. 2022 (円2,249 Mil) and increased from Dec. 2022 (円2,249 Mil) to Dec. 2023 (円3,003 Mil).

K Pharma Additional Paid-In Capital Historical Data

The historical data trend for K Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Additional Paid-In Capital Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Additional Paid-In Capital

699.45

2,249.25

3,003.34

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial			2,249.25	2,249.25	2,249.25	3,003.34	3,003.34

K Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

K Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of K Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines